Changing Telehealth Rules
PODCAST: Williams Mullen's Benefits Companion - Health Plan Transparency Requirements
PODCAST: Williams Mullen's Benefits Companion - Group Health Plan Service Provider Compensation Disclosure Requirements
Podcast: What's New for Insurers in Mental Health Parity Compliance - Diagnosing Health Care
PODCAST: Williams Mullen's Benefits Companion - Employee Retention Tax Credit Expansion
Department of Labor Imposes Additional Requirement on Employer-Provided Health Services
COVID-19 Relief in 2021: What Small Businesses Need to Know
On-Demand Webinar | Navigating Leave and Disability Protection Laws During COVID-19: A Practical Guide for California Employers
COVID-19 in the Workplace - PPP Update, COVID Plans from the Biden Transition Team, Higher Education Relief Package Provision, COVID WARN Act Developments
PODCAST: Williams Mullen's Benefits Companion - New Round of COVID-19 Relief Expands Assistance for Employers
As the new year begins, change is afoot inside the Beltway as the 119th Congress gets underway and Washington prepares for President Trump’s second administration. While change is bringing uncertainty on some fronts, health...more
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
This first part of a two-part series on U.S. regulation of artificial intelligence systems provides an overview and modern context for the existing regulatory, legal and risk management landscape for AI systems in the U.S.,...more
Websites play a vital role for organizations. They facilitate communication with consumers, constituents, patients, employees, donors, and the general public. They project an organization’s image and promote goodwill, provide...more
As we approach the middle of the first quarter of 2023, private equity firms have continued to demonstrate their interest in investing in digital health. This does not come as a surprise, as most startups in the healthcare...more
Perhaps missed over the holidays, the mammoth $1.7 trillion Consolidated Appropriations Act of 2023 (the Act) was signed into law by President Biden on December 29, 2022. It includes record levels of funding for a wide range...more
2022 was a big year for the pharmaceutical and biotechnology sectors. Novel technologies emerged at a rapid clip. The Food and Drug Administration (“FDA” or the “Agency”) approved over forty novel drugs and biologics and...more
On June 16, 2022, the Federal Trade Commission (FTC) issued a report to Congress titled, “Combatting Online Harms Through Innovation,” examining whether artificial intelligence (AI) is a useful tool to combat the...more